The search for alternatives to antibiotics creates a new global technological race

0

DUBLIN, April 13, 2022 /PRNewswire/ — The “Antibiotic Resistance Markets – Therapeutics by Pathogen and Therapy Type. With situational analysis, guides for executives and investors, and personalization.” report has been added to from ResearchAndMarkets.com offer.

The report has identified 6 major key opportunities in this space and developed market forecasts.

Antimicrobial resistance creates new types of infections and “superbugs” that are resistant to current antibiotics. New technologies (and new drugs) are being developed to capture this growing market.

The report also looked at the technology table, giving you a plain language understanding of the different ways pathogens and infections can be treated, including an explanation of the key role diagnostics will play. This is a market with many players, there are more than 100 biotechnology companies profiled in the report. The report summarizes the technologies they use.

Make investment decisions and valuations with confidence using the latest data. The report includes a five-year market forecast.

Main topics covered:

Snapshot of a dynamic market

Market players – Roles and impacts

  • Drug Manufacturers – Larger/Pharmaceutical
  • Drug Manufacturers – Generic
  • Contract research and manufacturing
  • In vitro diagnostic industry
  • Drug marketing companies
  • Biotechnology companies
  • Regulatory bodies

Understanding Antimicrobial Resistance

  • What is Antimicrobial Resistance (AMR)
  • Bacteria and other microbes
  • The history of antibiotics
  • The role of breeding
  • The implications of horizontal transfer
  • The threat of RAM

The Changing Path to New Antibiotics and Technologies

The Key Role of Diagnostics in RAM

The RAM Market Opportunity

The main market opportunities in RAM

  • Streptococcus Pneumoniae (DRSP)
  • Campylobacter (DRC)
  • Clostridium difficile (CD)
  • Staphylococcus aureus (MRSA)
  • Neisseria gonorrhoeae (DRNG)
  • Salmonella (DRNTS)

Opportunities for the development of therapeutic technologies

  • Using viruses against bacteria
  • Hydrolytic enzymes join the fight
  • Antibody
  • Vaccines
  • Probiotic technology
  • Peptides against pathogens
  • Obsolete mining sciences
  • CRISPR antibiotics

Antibiotic resistance Recent developments

  • The Neglected RAM Pandemic
  • New combination of anti-resistance antibiotics
  • CDC Awards $22 million to combat antimicrobial resistance
  • Antibiotic resistance foiled by supercomputers
  • STIs reach record levels
  • New research using nanoparticles to boost waning antibiotics
  • OpGen Receives FDA Clearance for AMR Panel
  • CDC updates STI diagnosis and treatment guidelines
  • Positive associations between AM use in animals and AMR in humans
  • PEW Antibiotics Pipeline Results

The main biotechnology companies and their technology

  • Therapeutic Melinta
  • Arsanis
  • Phage Technologies SA
  • Westway Health
  • Tetraphase Pharmaceuticals
  • BioVersys GmbH
  • Nabriva Therapeutic
  • Macrolide Pharmaceuticals
  • Nemesis Bioscience
  • C3J Therapeutics, Inc.
  • Epibiome
  • Discuva
  • SmartPhage.
  • AmpliPhi Biosciences
  • Pherecydes Pharma
  • Microos
  • Procarta Biosystems
  • Lumavita
  • Madam Therapeutic
  • Priaxon
  • Biolytx Pharmaceuticals
  • AntibioTx
  • Xellia Pharmaceuticals
  • Paratek Pharmaceuticals
  • Synereca Pharmaceuticals
  • Allecra Therapeutic
  • fixed phage
  • Enanta Pharmaceuticals, Inc.
  • disheartened
  • Promise
  • biosergene
  • Pharmaceutical Innovation
  • Aviragen Therapeutic
  • Achillion Pharmaceuticals
  • ImmunNovative Developments, SL
  • Achaogen, Inc.
  • SelectX Pharmaceuticals, Inc.
  • TaiGen Biotechnology Co., Ltd.
  • Theravance Biopharma
  • Abbie
  • KYORIN Pharmaceutical Co., Ltd.
  • Iterum Therapeutic Limited
  • Therapeutic Forge
  • Alopexx Vaccine LLC
  • Integrated Biotherapeutics
  • Hennepin Life Sciences
  • Fedora Pharmaceuticals Inc.
  • Contrafect Corporation
  • Basilea Pharmaceutica Ltd.
  • Ai Curis
  • RedHill Biopharma
  • Redx Pharma Plc/ Redx Anti Infectives Ltd.
  • ABAC therapy
  • Alaxia SAS
  • Antabio SAS
  • Auspherix SA
  • BioFilm Pharma
  • Centauri Therapeutics Ltd.
  • Combioxin SA
  • From Volterra
  • Debiopharm International SA
  • Deinobiotics/Deinove
  • Destiny Pharma plc
  • Eligo Bioscience
  • Helperby Therapeutics Ltd
  • Karveel Pharmaceuticals
  • Maat Pharma
  • Motif BioSciences, Inc / Motif Bio PLC
  • Mutabilis SAS
  • Neem Biotech Ltd
  • Northern Antibiotics Oy (Ltd)
  • Nosopharma
  • NovaBiotics Ltd
  • Phico Therapeutics Ltd.
  • Polyphor Ltd
  • QureTech Bio AB
  • SetLance srl
  • Ultupharma AB
  • Vaxdyn
  • Vibiosphene
  • Bioaster
  • Vivexia
  • KBP Biosciences
  • Absynth organic products
  • Spero Therapeutic
  • Merck
  • Symphogene
  • Biography of Warp Drive.
  • Johnson & Johnson (Janssen)
  • Pfizer
  • Allergan
  • GlaxoSmithKline
  • Novartis
  • Gilead Sciences
  • Astra Zeneca
  • Sanofi
  • Shionogi Inc.
  • cipla
  • DSM Sinochem Pharmaceuticals
  • Wockhardt Ltd.
  • VenatoRx Pharmaceuticals
  • MicuRx
  • Therapeutic Entasis
  • Merlion Pharmaceuticals
  • Aridis Pharmaceuticals Inc.

For more information on this report, visit https://www.researchandmarkets.com/r/ohqqvk

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716

SOURCE Research and Markets

Share.

About Author

Comments are closed.